EQT announces intention to sell part of its shareholding in Enity Holding

EQT’s Butterfly HoldCo (EQT VII) has launched an accelerated bookbuild to sell approximately 8.0 million shares in Enity Holding AB—about 16% of the company and roughly 40% of the Main Shareholder’s stake—with ABG Sundal Collier, Nordea and SEB as joint bookrunners; the placing targets institutional/qualified investors and will not be registered in the U.S. Assuming full placement, EQT would retain about 12.0 million shares (≈24% of votes), the company will receive no proceeds and the remaining stake is subject to a 60‑day lock‑up (waivable), a move that increases near‑term free float and could put downward pressure on Enity’s share price while leaving EQT as a significant, non‑controlling shareholder.

Analysis

Butterfly HoldCo Pte. Ltd., indirectly controlled by the EQT VII fund, has launched an accelerated bookbuild to sell approximately 8.0 million shares in Enity Holding AB, representing roughly 16% of Enity and about 40% of the Main Shareholder’s stake, with ABG Sundal Collier, Nordea and SEB acting as joint bookrunners. The placing targets institutional/qualified investors (offered outside the U.S. under Regulation S and to Qualified Institutional Buyers under Rule 144A), no prospectus will be prepared and Enity will receive no proceeds from the transaction.

Assuming full placement, the Main Shareholder would retain ~12.0 million shares, or about 24% of share capital and voting rights, and has agreed to a 60‑day lock‑up on the remaining holdings subject to customary waivers, preserving EQT as a significant but non‑controlling investor. The accelerated bookbuild increases near‑term free float and, combined with the limited lock‑up and potential waivers, creates a meaningful risk of near‑term selling pressure on Enity’s share price; market signals in the release indicate a mildly negative, cautious tone with modest market‑impact potential.

Regulatory constraints on U.S. retail distribution and the institutional targeting may narrow the bidder pool and affect execution pricing; because Enity receives no capital from the sale, this is a liquidity event for the Main Shareholder rather than a corporate recapitalization, so investors should focus on placement coverage, execution price and any subsequent waiver or secondary sales when updating valuation and liquidity assumptions.

Key Decisions for Investors

• Consider reducing or hedging near‑term exposure to Enity ahead of the accelerated bookbuild to protect against immediate selling pressure and monitor execution size and placement price relative to the market
• Watch the placing outcome closely — confirm whether all 8 million shares are placed, the execution price (and any material discount) and any waiver to the 60‑day lock‑up — and adjust tactical positioning accordingly
• Reassess medium‑term conviction based on EQT retaining ~24% ownership: treat EQT as a large strategic but non‑controlling holder when modeling governance and strategic outcomes
• Do not assume corporate balance‑sheet benefit from this transaction since Enity receives no proceeds; factor that into short‑term liquidity, capex and funding scenarios